v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 134,598 $ 125,189
Restricted cash equivalents 115 5,577
Marketable securities, at fair value 34,223 42,774
Restricted marketable securities, at fair value 35,367 30,352
Accounts receivable, net (less allowances: $113,917 and $119,305) 309,595 281,303
Notes receivable — short–term portion, net (less allowances: $$25,022 and $$25,931) 24,504 31,243
Inventories and supplies 15,533 16,797
Taxes receivable 0 22,246
Prepaid expenses and other current assets 28,826 20,934
Total current assets 582,761 576,415
Property and equipment, net 30,777 27,586
Goodwill 90,456 79,797
Other intangible assets (less accumulated amortization of $45,264 and $42,931) 16,860 6,964
Notes receivable — long–term portion, net (less allowances: $2,924 and $1,776) 42,350 25,209
Deferred compensation funding, at fair value 59,018 55,909
Deferred tax assets 18,639 18,472
Other long-term assets 9,537 3,901
Total assets 850,398 794,253
Current liabilities:    
Accounts payable 92,170 77,382
Accrued payroll and related taxes 54,661 31,400
Other accrued expenses and current liabilities 36,505 37,222
Taxes payable 1,733 0
Accrued insurance claims 21,353 24,371
Total current liabilities 206,422 170,375
Accrued insurance claims — long-term 41,156 46,142
Deferred compensation liability — long-term 59,122 56,276
Lease liability — long-term 11,433 9,659
Other long-term liabilities 814 1,591
Commitments and contingencies (Note 17)
STOCKHOLDERS’ EQUITY:    
Common stock, $0.01 par value; 200,000 shares authorized; 77,300 and 76,821 shares issued, and 67,432 and 69,596 shares outstanding 773 768
Additional paid-in capital 334,296 327,956
Retained earnings 357,304 283,668
Accumulated other comprehensive loss, net of taxes (3,360) (448)
Common stock in treasury, at cost, 9,868 and 7,225 shares (157,562) (101,734)
Total stockholders’ equity 531,451 510,210
Total liabilities and stockholders’ equity $ 850,398 $ 794,253